Iranian Red Crescent Medical Journal

Published by: Kowsar

Comparing the Effect of Dill Seed Vaginal Cream, with a Persian Traditional Base, and 1% Clotrimazole Vaginal Cream on Vulvovaginal Candidiasis: A Double-Blind, Randomized Clinical Trial

Zohreh Sarhadinejad 1 , Haleh Tajadini 2 , Mojgan Tansaz 3 , Abbas Bahrampour 4 , Zarrin Sarhadynejad 1 , Mehdi Ansari 5 , Fariba Sharififar 6 , Maryam Iranpour 7 and Zohreh Salari 8 , *
Authors Information
1 Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran
2 Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
3 Department of Persian Medicine, School of Persian Medicine, Material Medical Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4 Department of Epidemiology and Biostatistics, School of Public Health, Kerman University Medical Sciences, Kerman, Iran
5 Department of Drug and Food Control, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
6 Department of Pharmacognosy, Faculty of Pharmacy, Kerman University of Medical Sciences, Kerman, Iran
7 Pathology and Stem cell Research Center, Kerman University of Medical Sciences, Kerman, Iran
8 Obstetrics and Gynecology Center, Afzalipour School of Medicine, Kerman University of Medical Sciences, Kerman, Iran
Article information
  • Iranian Red Crescent Medical Journal: October 2018, 20 (10); e74211
  • Published Online: October 14, 2018
  • Article Type: Research Article
  • Received: May 2, 2018
  • Revised: August 2, 2018
  • Accepted: August 12, 2018
  • DOI: 10.5812/ircmj.74211

To Cite: Sarhadinejad Z, Tajadini H, Tansaz M, Bahrampour A, Sarhadynejad Z, et al. Comparing the Effect of Dill Seed Vaginal Cream, with a Persian Traditional Base, and 1% Clotrimazole Vaginal Cream on Vulvovaginal Candidiasis: A Double-Blind, Randomized Clinical Trial, Iran Red Crescent Med J. 2018 ; 20(10):e74211. doi: 10.5812/ircmj.74211.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Sobel JD. Pathogenesis of recurrent vulvovaginal candidiasis. Curr Infect Dis Rep. 2002;4(6):514-9. doi: 10.1007/s11908-002-0038-7. [PubMed: 12433327].
  • 2. Quan M. Vaginitis: Diagnosis and management. Postgrad Med. 2010;122(6):117-27. doi: 10.3810/pgm.2010.11.2229. [PubMed: 21084788].
  • 3. Nguyen Y, Lee A, Fischer G. Quality of life in patients with chronic vulvovaginal candidiasis: A before and after study on the impact of oral fluconazole therapy. Australas J Dermatol. 2017;58(4):e176-81. doi: 10.1111/ajd.12487. [PubMed: 27170259].
  • 4. Farshbaf-Khalili A, Mohammadi-Ghalehbin B, Shahnazi M, Asghari S, Javadzadeh Y, Azghani P. Comparing the effect of garlic, zataria multiflora and clotrimazole vaginal cream 2% on improvement of fungal vaginitis: A randomized controlled trial. Iran Red Crescent Med J. 2016;18(12). doi: 10.5812/ircmj.29262.
  • 5. Kalkanci A, Guzel AB, Khalil II, Aydin M, Ilkit M, Kustimur S. Yeast vaginitis during pregnancy: Susceptibility testing of 13 antifungal drugs and boric acid and the detection of four virulence factors. Med Mycol. 2012;50(6):585-93. doi: 10.3109/13693786.2012.662597. [PubMed: 22369624].
  • 6. Richter SS, Galask RP, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol. 2005;43(5):2155-62. doi: 10.1128/JCM.43.5.2155-2162.2005. [PubMed: 15872235]. [PubMed Central: PMC1153777].
  • 7. Ahmad A, Khan AU. Prevalence of Candida species and potential risk factors for vulvovaginal candidiasis in Aligarh, India. Eur J Obstet Gynecol Reprod Biol. 2009;144(1):68-71. doi: 10.1016/j.ejogrb.2008.12.020. [PubMed: 19261369].
  • 8. Sobel JD. Vulvovaginal candidosis. Lancet. 2007;369(9577):1961-71. doi: 10.1016/S0140-6736(07)60917-9. [PubMed: 17560449].
  • 9. Iavazzo C, Gkegkes ID, Zarkada IM, Falagas ME. Boric acid for recurrent vulvovaginal candidiasis: The clinical evidence. J Womens Health (Larchmt). 2011;20(8):1245-55. doi: 10.1089/jwh.2010.2708. [PubMed: 21774671].
  • 10. Fardiazar Z, Ronaci F, Torab R, Goldust M. Vulvovaginitis candidiasis recurrence during pregnancy. Pak J Biol Sci. 2012;15(8):399-402. doi: 10.3923/pjbs.2012.399.402. [PubMed: 24199471].
  • 11. Kutzer E, Oittner R, Leodolter S, Brammer KW. A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial. Eur J Obstet Gynecol Reprod Biol. 1988;29(4):305-13. doi: 10.1016/0028-2243(88)90071-8. [PubMed: 2852609].
  • 12. Khoza S, Moyo I, Ncube D. Comparative Hepatotoxicity of Fluconazole, Ketoconazole, Itraconazole, Terbinafine, and Griseofulvin in Rats. J Toxicol. 2017;2017:6746989. doi: 10.1155/2017/6746989. [PubMed: 28261269]. [PubMed Central: PMC5316457].
  • 13. Adiban Fard F, Tork Zahrani S, Akbarzadeh Bagheban A, Mojab F. Therapeutic effects of nigella sativa linn (black cumin) on Candida albicans vaginitis. Arch Clin Infect Dis. 2015;10(1). doi: 10.5812/archcid.22991.
  • 14. Liu X, Ma Z, Zhang J, Yang L. Antifungal Compounds against Candida Infections from Traditional Chinese Medicine. Biomed Res Int. 2017;2017:4614183. doi: 10.1155/2017/4614183. [PubMed: 29445739]. [PubMed Central: PMC5763084].
  • 15. Gavanji S, Zaker SR, Nejad ZG, Bakhtari A, Bidabadi ES, Larki B. Comparative efficacy of herbal essences with amphotricin B and ketoconazole on Candida albicans in the in vitro condition. Integr Med Res. 2015;4(2):112-8. doi: 10.1016/j.imr.2015.01.003. [PubMed: 28664116]. [PubMed Central: PMC5481788].
  • 16. Borris RP. Natural products research: Perspectives from a major pharmaceutical company. J Ethnopharmacol. 1996;51(1-3):29-38. doi: 10.1016/0378-8741(95)01347-4. [PubMed: 9213624].
  • 17. Kaur GJ, Arora DS. Antibacterial and phytochemical screening of Anethum graveolens, Foeniculum vulgare and Trachyspermum ammi. BMC Complement Altern Med. 2009;9:30. doi: 10.1186/1472-6882-9-30. [PubMed: 19656417]. [PubMed Central: PMC2736926].
  • 18. Sarhadynejad Z, Sharififar F, Pardakhty A, Nematollahi MH, Sattaie-Mokhtari S, Mandegary A. Pharmacological safety evaluation of a traditional herbal medicine "Zereshk-e-Saghir" and assessment of its hepatoprotective effects on carbon tetrachloride induced hepatic damage in rats. J Ethnopharmacol. 2016;190:387-95. doi: 10.1016/j.jep.2016.07.043. [PubMed: 27426508].
  • 19. Sarhadynejad Z, Pardakhty A, Mandegary A, Afsharypuor S, Sharififar F. Physicochemical characterization, standardization and in vitro determination of radical scavenging activity of Zereshk-e- Saghir, a traditional preparation, and its ingredients. J Young Pharm. 2017;9(2):224-9. doi: 10.5530/jyp.2017.9.44.
  • 20. Jana S, Shekhawat GS. Anethum graveolens: An Indian traditional medicinal herb and spice. Pharmacogn Rev. 2010;4(8):179-84. doi: 10.4103/0973-7847.70915. [PubMed: 22228959]. [PubMed Central: PMC3249919].
  • 21. Zabka M, Pavela R. Antifungal efficacy of some natural phenolic compounds against significant pathogenic and toxinogenic filamentous fungi. Chemosphere. 2013;93(6):1051-6. doi: 10.1016/j.chemosphere.2013.05.076. [PubMed: 23800587].
  • 22. Zeng H, Tian J, Zheng Y, Ban X, Zeng J, Mao Y, et al. In vitro and in vivo activities of essential Oil from the seed of anethum graveolens L. against Candida spp. Evid Based Complement Alternat Med. 2011;2011:659704. doi: 10.1155/2011/659704. [PubMed: 21716714]. [PubMed Central: PMC3119046].
  • 23. Aghili Khorasani Alavi Shirazi MH. Makhzan al-adviyah Tehran. Sabz arang,Tehran University; 2009. Persian.
  • 24. Azamkhan M. Exir-e-Azam. Tehran: Research Institute for Islamic and Complementary Medicine, Tehran University of Medical Sciences; 2004. Persian.
  • 25. Ishikawa T, Kudo M, Kitajima J. Water-soluble constituents of dill. Chem Pharm Bull (Tokyo). 2002;50(4):501-7. doi: 10.1248/cpb.50.1471. [PubMed: 11963998].
  • 26. Bahadoran P, Rokni FK, Fahami F. Investigating the therapeutic effect of vaginal cream containing garlic and thyme compared to clotrimazole cream for the treatment of mycotic vaginitis. Iran J Nurs Midwifery Res. 2010;15(Suppl 1):343-9. [PubMed: 22069409]. [PubMed Central: PMC3208935].
  • 27. Fouladi Z, Afshari P, Gharibi T, Dabbagh M. [The comparison oF Zataria multiflora boiss (Avishan Shirazi) and Clotrimazol vaginal cream in the treatment of candidiasis vaginitis]. Iran South Med J. 2009;12(3):214-24. Persian.
  • 28. Simbar M, Azarbad Z, Mojab F, Majd HA. A comparative study of the therapeutic effects of the Zataria multiflora vaginal cream and metronidazole vaginal gel on bacterial vaginosis. Phytomedicine. 2008;15(12):1025-31. doi: 10.1016/j.phymed.2008.08.004. [PubMed: 18824338].
  • 29. Ma B, Ban X, Huang B, He J, Tian J, Zeng H, et al. Interference and mechanism of dill seed essential oil and contribution of carvone and limonene in preventing sclerotinia rot of rapeseed. PLoS One. 2015;10(7):131733. doi: 10.1371/journal.pone.0131733. [PubMed: 26133771]. [PubMed Central: PMC4489822].
  • 30. Chen Y, Zeng H, Tian J, Ban X, Ma B, Wang Y. Antifungal mechanism of essential oil from Anethum graveolens seeds against Candida albicans. J Med Microbiol. 2013;62(Pt 8):1175-83. doi: 10.1099/jmm.0.055467-0. [PubMed: 23657528].
  • 31. Naseri M, Mojab F, Khodadoost M, Kamalinejad M, Davati A, Choopani R, et al. The study of anti-inflammatory activity of oil-based dill (Anethum graveolens L.) extract used topically in formalin-induced inflammation male rat paw. Iran J Pharm Res. 2012;11(4):1169-74. [PubMed: 24250550]. [PubMed Central: PMC3813168].
  • 32. Saghafi N, Karjalian M, Ghazanfarpour M, Khorsand I, Rakhshandeh H, Mirteimouri M, et al. The effect of a vaginal suppository formulation of dill (Anethum graveolens) in comparison to clotrimazole vaginal tablet on the treatment of vulvovaginal candidiasis. J Obstet Gynaecol. 2018:1-4. doi: 10.1080/01443615.2018.1432578. [PubMed: 29553834].
  • 33. Teodoro GR, Ellepola K, Seneviratne CJ, Koga-Ito CY. Potential use of phenolic acids as anti-candida agents: A review. Front Microbiol. 2015;6:1420. doi: 10.3389/fmicb.2015.01420. [PubMed: 26733965]. [PubMed Central: PMC4685070].
  • 34. Sarhadinejad Z, sharififar F, Sarhadynejad Z, Salari Z, Tajadini H, Mohamadi F, et al. Formulation and characterization of dill seed vaginal cream based on a traditional medicine. J Pharm Res Int. 2018;23(1):1-10. doi: 10.9734/jpri/2018/42143.
  • 35. Iranian Herbal Pharmacopoeia Committe. [Iranian Herbal Pharmacopoeia.]. Tehran: Ministry of health treatment and Medical Education Food and Drug Department; 2002. 5 p. Persian.
  • 36. Smeekens SP, van de Veerdonk FL, Kullberg BJ, Netea MG. Genetic susceptibility to Candida infections. EMBO Mol Med. 2013;5(6):805-13. doi: 10.1002/emmm.201201678. [PubMed: 23629947]. [PubMed Central: PMC3779444].
  • 37. Oliveira VM, Carraro E, Auler ME, Khalil NM. Quercetin and rutin as potential agents antifungal against Cryptococcus spp. Braz J Biol. 2016;76(4):1029-34. doi: 10.1590/1519-6984.07415. [PubMed: 27166572].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments